Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 121-130 of 161 for pancreatic cancer

Edit search filters
  1. Exploring Duodenal Biopsies as a Biomarker of Pancreatic Cancer

    Rochester, MN

  2. A Study of Leukemia Inhibitory Factor Biomarker Monitoring Progression and Treatment Response of Locally-advanced Unresectable and Metastatic Pancreatic Cancer Therapies

    Jacksonville, FL

  3. A Study to Evaluate the NanoKnife SYstem for Stage 3 Pancreatic Cancer

    Jacksonville, FL, Rochester, MN

  4. A Study to Detect Pancreatic Cancer Using Circulating Tumor Markers

    Rochester, MN

  5. Early pancreatic cancer detection

    Jacksonville, FL

  6. A Study of Pancreatic Cancer Risk

    Rochester, MN

  7. Identifying Gene Modifiers of Melanoma and Pancreatic Cancer Susceptibility

    Rochester, MN

  8. A Study to Investigate Blood-derived Circulating Tumor DNA, Circulating Tumor RNA, and Circulating Tumor miRNA in Pancreatic Cancer Patients

    Jacksonville, FL

  9. Institutional Analysis of Non-metastatic Pancreatic Adenocarcinoma Outcomes from 2011-2016

  10. A Study to Create a Registry for Patients at High-Risk for Pancreatic Cancer

    Rochester, MN

.

Mayo Clinic Footer